Risk factors for total joint arthroplasty infection in patients receiving tumor necrosis factor α-blockers: a case-control study. - Wikidata - wikimedia - TriplyDB

Risk factors for total joint arthroplasty infection in patients receiving tumor necrosis factor α-blockers: a case-control study.

Risk factors for total joint arthroplasty infection in patients receiving tumor necrosis factor α-blockers: a case-control study.

http://www.wikidata.org/entity/Q34153015

about

An Insight into Methods and Practices in Hip Arthroplasty in Patients with Rheumatoid Arthritis Patient, Surgery, and Hospital Related Risk Factors for Surgical Site Infections following Total Hip Arthroplasty Hydroxyapatite coating does not improve uncemented stem survival after total hip arthroplasty!Postoperative complications in patients with rheumatoid arthritis using a biological agent - A systematic review and meta-analysis.Increased risk of revision for infection in rheumatoid arthritis patients with total hip replacements Rheumatoid Arthritis Does Not Increase Risk of Short-term Adverse Events after Total Knee Arthroplasty: A Retrospective Case-control Study.Harms of TNF inhibitors in rheumatic diseases: a focused review of the literature.Continuation of TNF blockade in patients with inflammatory rheumatic disease. An observational study on surgical site infections in 1,596 elective orthopedic and hand surgery procedures.Elevation of serum tumor necrosis factor α in patients with periprosthetic osteolysis: a case-control study.Risk factors for infection following total joint arthroplasty in rheumatoid arthritis.Patterns and associated risk of perioperative use of anti-tumor necrosis factor in patients with rheumatoid arthritis undergoing total knee replacement Should anti-TNF therapy be discontinued in rheumatoid arthritis patients undergoing elective orthopaedic surgery? A systematic review of the evidence.Perioperative management of the patient with rheumatoid arthritis.Perioperative timing of infliximab and the risk of serious infection after elective hip and knee arthroplasty.Moderating effects of immunosuppressive medications and risk factors for post-operative joint infection following total joint arthroplasty in patients with rheumatoid arthritis or osteoarthritis.Risk factors for surgical site infection and delayed wound healing after orthopedic surgery in rheumatoid arthritis patients.[Safety of immunosuppressants].Infection risk after orthopedic surgery in patients with inflammatory rheumatic diseases treated with immunosuppressive drugs.Perioperative Management of Patients with Inflammatory Rheumatic Diseases Undergoing Major Orthopaedic Surgery: A Practical Overview.

P2860

Q26799966-B380FAF0-A21B-4D35-B313-78010E753BC1 Q28082491-965F10BE-D3B1-4EAD-AF45-56615BA93DDC Q35197607-D0FC7F76-42EA-4EBF-8F1E-F293D2B54C1D Q35559234-F6F46A03-B89B-4C17-963C-A058FB3CF003 Q35885274-6745FBEA-0DE0-4CE0-A6FD-979E5914A061 Q36588424-49D96F12-2E32-433B-8BC3-6DE6353BF7FB Q37189376-6AD41745-614E-4B3F-B7E3-375BDF8B5761 Q37292803-3A8A2479-5C86-4419-8B99-7014B99D7852 Q37472450-2E951823-43DE-470A-B559-C720C246B411 Q37486363-ECC1EDD0-446A-4094-98B1-812B69287198 Q37604968-21511E94-0E50-4077-A5CE-FD2D49392240 Q37907921-965A03D5-ACED-4A77-9B86-5EC8C2E58C16 Q38230865-EE97A00C-EA22-418E-A3AF-259871385F36 Q40355795-E173AB64-C3D6-49C1-BDCB-ECA29D359BF3 Q40520453-1F52B9E6-3E8C-4752-95F4-1331CFCD063B Q40552131-FCC86E3E-B9FE-423D-AE4F-E4232C45F9B8 Q41929021-CFAF9D80-F8F6-4B18-A418-0AB01A8F8C88 Q44964652-B2575E33-42F3-4103-A269-75FEACF734EC Q52349399-66AB5EC7-6B8A-481A-A852-9B5D094B46D4

P2860

Risk factors for total joint arthroplasty infection in patients receiving tumor necrosis factor α-blockers: a case-control study.

http://www.wikidata.org/entity/Q34153015

description

2010 nî lūn-bûn

@nan

2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Risk factors for total joint a ...... lockers: a case-control study.

@ast

Risk factors for total joint a ...... lockers: a case-control study.

@en

Risk factors for total joint a ...... lockers: a case-control study.

@nl

type

label

Risk factors for total joint a ...... lockers: a case-control study.

@ast

Risk factors for total joint a ...... lockers: a case-control study.

@en

Risk factors for total joint a ...... lockers: a case-control study.

@nl

prefLabel

Risk factors for total joint a ...... lockers: a case-control study.

@ast

Risk factors for total joint a ...... lockers: a case-control study.

@en

Risk factors for total joint a ...... lockers: a case-control study.

@nl

P1433

Q34153015-9BAF7599-5A6E-4A5F-8705-7271634732B5

P1476

Q34153015-1C028CDF-1164-404C-BEE8-4E6ED61159CD

P2093

Q34153015-3D760334-9E9C-4504-9489-3D71D233DF01

Q34153015-41857DAD-6630-410B-BF7F-FCBE78ABF0E2

Q34153015-46750211-3D9D-455F-8545-2D5E219F725C

Q34153015-5745B2DD-1049-44FC-96E5-92E685246BFF

Q34153015-5A2F294F-21AB-437E-A101-51F5C5AFB324

Q34153015-653EB298-533C-44AF-9339-35053D41675B

Q34153015-8F9ADBFA-3BCF-4D6F-85BC-74BC7BB49BE6

Q34153015-A8EBE831-3C27-4A49-8DFB-11E6BCC70487

P2860

Q34153015-081DFEC6-FA05-4A87-AB54-B225AE86C9C1

Q34153015-09AE6A32-816C-466E-9AD8-A7FCF3AD27C6

Q34153015-13FCB4E0-E584-410F-A63F-59F9D5D2227A

Q34153015-1904017A-A2E3-47A0-84EE-F62A71B9D153

Q34153015-38C23139-2297-4CE4-9B07-7F58B1E86071

Q34153015-41ACB95D-80B3-4309-9F25-E5E7B4E98AF8

Q34153015-56829FC8-8E91-4CF2-A8CC-DB447EB70ADB

Q34153015-611C51C3-6784-4EE0-A734-6E9F334CCC36

Q34153015-74E5D31A-1A5C-4453-9D3A-589581E05000

Q34153015-7758F475-2580-416F-9599-A4E56B16C423

P2888

Q34153015-35841812-7502-482F-82F6-B91F143E9666

P304

Q34153015-9663458F-DBC4-4629-A832-97298B00ADD0

P31

Q34153015-82AC23FE-9C59-435B-A805-5833209E19DE

P356

Q34153015-5C09B62F-5360-4456-B6EE-86FB99B74BA3

P433

Q34153015-4BF8D8A7-B2DC-4941-8A34-5604A4756E33

P478

Q34153015-D8970364-ED6B-45A7-A782-FC8FB32E7BD9

P50

Q34153015-8342C597-773F-460B-9F81-80B3E0538086

Q34153015-B7934A1F-AF44-4649-BB82-06174836F88B

Q34153015-EA8D82DC-E155-4A92-871B-2E3AD6AD0684

Q34153015-FF5E5F09-306F-40F8-BADD-53274EFF69C3

P577

Q34153015-A3B01F9A-96B9-4B75-9543-D5833B1C8E90

P5875

Q34153015-AE6D3A46-CA3B-4785-BB14-2E6D19D95A3F

P6179

Q34153015-64DA5A37-572C-4BD0-BBED-42D5388723C9

P698

Q34153015-CCDD22A5-167A-4AB4-AB8E-E6572DAED038

P932

Q34153015-54AE0867-C494-4DF2-A277-5774239938F0

P356

P1433

Arthritis Research and Therapy

P1476

Risk factors for total joint a ...... lockers: a case-control study.

@en

P2093

Christian Michelet

http://www.w3.org/2001/XMLSchema#string

Dalenda Gherissi

http://www.w3.org/2001/XMLSchema#string

Dominique Salmon

http://www.w3.org/2001/XMLSchema#string

Florence Tubach

http://www.w3.org/2001/XMLSchema#string

Marie-Hélène Guyot

http://www.w3.org/2001/XMLSchema#string

Mélanie Gilson

http://www.w3.org/2001/XMLSchema#string

Pierre Dellamonica

http://www.w3.org/2001/XMLSchema#string

Xavier Mariette

http://www.w3.org/2001/XMLSchema#string

P2860

Infection after total knee arthroplasty. A retrospective study of the treatment of eighty-one infections

Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent

Methotrexate and early postoperative complications in patients with rheumatoid arthritis undergoing elective orthopaedic surgery

Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials.

Increasing risk of revision due to deep infection after hip arthroplasty.

Risk of tuberculosis is higher with anti-tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: The three-year prospective French Research Axed on Tolerance of Biotherapies registry.

Radiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti-tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy: a randomized, placebo-cont

Declining use of orthopedic surgery in patients with rheumatoid arthritis? Results of a long-term, population-based assessment.

Joint surgery in the Utrecht Rheumatoid Arthritis Cohort: the effect of treatment strategy

The RATIO observatory: French registry of opportunistic infections, severe bacterial infections, and lymphomas complicating anti-TnFalpha therapy.

P2888

P304

R145

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/AR3087

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P50

Maxime Dougados

Jean-Marie Berthelot

Daniel Wendling

P577

2010-07-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

45269555

http://www.w3.org/2001/XMLSchema#string

P6179

1023525276

http://www.w3.org/2001/XMLSchema#string

P698

20637100

http://www.w3.org/2001/XMLSchema#string

P932

2945039

http://www.w3.org/2001/XMLSchema#string